In addition, patients with melanoma who expressed lower levels of NF2, TEAD3, and TEAD4 were associated with longer OS than those who expressed lower levels of NF2, TEAD3, and TEAD4 (Figures 2D–F). Here, TEAD4 is linked to melanoma.